LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 64

Search options

  1. Article: Congenital Aneurysm of the Muscular Interventricular Septum Associated With Bifascicular Block.

    Nguyen, Hoang H / Jay, Patrick Y

    Cureus

    2022  Volume 14, Issue 10, Page(s) e29994

    Abstract: Isolated congenital aneurysm of the muscular interventricular septum is rare. We present a patient with congenital aneurysm of the basal muscular ventricular septum, who also develops conduction abnormalities with first-degree heart block, right bundle ... ...

    Abstract Isolated congenital aneurysm of the muscular interventricular septum is rare. We present a patient with congenital aneurysm of the basal muscular ventricular septum, who also develops conduction abnormalities with first-degree heart block, right bundle branch block, and left posterior fascicular block. The case details the natural history of the aneurysm over a 10-year period follow-up during which the patient remained asymptomatic with evidence of regression of the aneurysm. Given the aneurysm's location close to the proximal right bundle and left posterior fascicle, we believe that the cause for the aneurysm also injured both fascicles resulting in bifascicular block. The diagnosis of bifascicular block was confirmed using the electrocardiogram-derived vectorcardiography loops. These conduction abnormalities have remained stable. The case illustrates the utility of vectorcardiography in diagnosing bundle branch conduction defects. The case also illustrates the importance of anatomical considerations when encountering congenital heart defects.
    Language English
    Publishing date 2022-10-06
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.29994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Molecules and microbes and cells, Oh My! What mothers give to us besides genes.

    Jay, Patrick Y / Watanabe, Michiko

    Birth defects research

    2019  Volume 110, Issue 20, Page(s) 1491–1493

    MeSH term(s) Female ; Humans ; Maternal Inheritance/genetics ; Maternal Inheritance/physiology ; Microbiota ; Mothers ; Pregnancy ; Prenatal Exposure Delayed Effects/physiopathology
    Language English
    Publishing date 2019-02-12
    Publishing country United States
    Document type Editorial ; Introductory Journal Article
    ISSN 2472-1727
    ISSN (online) 2472-1727
    DOI 10.1002/bdr2.1440
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Repurposing Normal Chromosomal Microarray Data to Harbor Genetic Insights into Congenital Heart Disease.

    Walton, Nephi A / Nguyen, Hoang H / Procknow, Sara S / Johnson, Darren / Anzelmi, Alexander / Jay, Patrick Y

    Biology

    2023  Volume 12, Issue 10

    Abstract: About 15% of congenital heart disease (CHD) patients have a known pathogenic copy number variant. The majority of their chromosomal microarray (CMA) tests are deemed normal. Diagnostic interpretation typically ignores microdeletions smaller than 100 kb. ... ...

    Abstract About 15% of congenital heart disease (CHD) patients have a known pathogenic copy number variant. The majority of their chromosomal microarray (CMA) tests are deemed normal. Diagnostic interpretation typically ignores microdeletions smaller than 100 kb. We hypothesized that unreported microdeletions are enriched for CHD genes. We analyzed "normal" CMAs of 1762 patients who were evaluated at a pediatric referral center, of which 319 (18%) had CHD. Using CMAs from monozygotic twins or replicates from the same individual, we established a size threshold based on probe count for the reproducible detection of small microdeletions. Genes in the microdeletions were sequentially filtered by their nominal association with a CHD diagnosis, the expression level in the fetal heart, and the deleteriousness of a loss-of-function mutation. The subsequent enrichment for CHD genes was assessed using the presence of known or potentially novel genes implicated by a large whole-exome sequencing study of CHD. The unreported microdeletions were modestly enriched for both known CHD genes and those of unknown significance identified using their de novo mutation in CHD patients. Our results show that readily available "normal" CMA data can be a fruitful resource for genetic discovery and that smaller deletions should receive more attention in clinical evaluation.
    Language English
    Publishing date 2023-09-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2661517-4
    ISSN 2079-7737
    ISSN 2079-7737
    DOI 10.3390/biology12101290
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation.

    Badri, Prajakta / Habtemariam, Bahru / Melch, Megan / Clausen, Valerie A / Arum, Seth / Li, Xingyu / Jay, Patrick Y / Vest, John / Robbie, Gabriel J

    Clinical pharmacokinetics

    2023  Volume 62, Issue 10, Page(s) 1509–1522

    Abstract: Background and objective: Variants of the transthyretin (TTR) gene cause hereditary transthyretin-mediated (hATTR) amyloidosis, or ATTRv amyloidosis (v for variant), which results from deposition of misfolded TTR protein as amyloid in organs and tissues. ...

    Abstract Background and objective: Variants of the transthyretin (TTR) gene cause hereditary transthyretin-mediated (hATTR) amyloidosis, or ATTRv amyloidosis (v for variant), which results from deposition of misfolded TTR protein as amyloid in organs and tissues. Patisiran is an RNA interference (RNAi) therapeutic that suppresses the hepatic production of TTR protein. Patisiran improves multiple clinical manifestations of hATTR amyloidosis in patients without liver transplantation (LT). Because the liver is the predominant source of circulating TTR, LT has been prescribed to eliminate the production of the variant TTR. However, the continued production of wild-type TTR can contribute to disease progression after LT. Patisiran could potentially address an unmet need in these affected patients. This clinical trial was conducted to evaluate the safety, efficacy, and pharmacokinetics (PK) and pharmacodynamics (PD) of patisiran in patients with hATTR amyloidosis with polyneuropathy progression after LT. In this paper, we describe the PK/PD of patisiran in post-LT patients and compare it with prior patisiran studies in healthy subjects and patients without LT.
    Methods: In an open-label study, patients (N = 23) with hATTR amyloidosis with polyneuropathy progression after LT received 0.3 mg/kg patisiran intravenously every 3 weeks (q3w) for 12 months. As a post hoc analysis, the PK and PD results from the current study were compared with prior patisiran studies in healthy volunteers from a Phase 1 study and in patients with hATTR amyloidosis without LT from Phase 2 and 3 studies.
    Results: The PK profile of patisiran siRNA (ALN-18328) and its 2 lipid excipients, DLin-MC3-DMA and PEG2000-C-DMG, in hATTR amyloidosis patients after LT was consistent with prior patisiran studies in non-LT subjects. Plasma PK profiles of ALN-18328 and DLin-MC3-DMA exhibited 2 phases, the first characterized by a short distribution half-life and the second by a minor peak and relatively long elimination half-life. The plasma concentrations of PEG
    Conclusions: The consistency of patisiran PK and PD between patients with and without LT suggests that neither LT nor concomitantly administered immunosuppressants influence hepatic uptake or RNAi activity of patisiran. The patisiran dosing regimen of 0.3 mg/kg q3w is appropriate for hATTR amyloidosis patients with or without LT.
    Clinical trial registration no: NCT03862807.
    MeSH term(s) Humans ; Liver Transplantation/adverse effects ; Prealbumin/genetics ; RNA, Small Interfering ; Amyloidosis
    Chemical Substances patisiran (50FKX8CB2Y) ; Prealbumin ; RNA, Small Interfering
    Language English
    Publishing date 2023-08-28
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 197627-8
    ISSN 1179-1926 ; 0312-5963
    ISSN (online) 1179-1926
    ISSN 0312-5963
    DOI 10.1007/s40262-023-01292-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Heritable Basis of Congenital Heart Disease: Past, Present, and Future.

    Nogee, Julie M / Jay, Patrick Y

    Circulation. Cardiovascular genetics

    2016  Volume 9, Issue 4, Page(s) 315–317

    MeSH term(s) Exome ; Heart Defects, Congenital/genetics ; Humans ; Mutation ; Pedigree
    Language English
    Publishing date 2016-08-16
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2477394-3
    ISSN 1942-3268 ; 1942-325X
    ISSN (online) 1942-3268
    ISSN 1942-325X
    DOI 10.1161/CIRCGENETICS.116.001559
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Rhythm genes sing more than one tune: noncanonical functions of cardiac ion channels.

    Akhirome, Ehiole / Jay, Patrick Y

    Circulation. Arrhythmia and electrophysiology

    2015  Volume 8, Issue 2, Page(s) 261–262

    MeSH term(s) Abnormalities, Drug-Induced/prevention & control ; Animals ; ERG1 Potassium Channel ; Embryonic Stem Cells/drug effects ; Ether-A-Go-Go Potassium Channels/antagonists & inhibitors ; Ether-A-Go-Go Potassium Channels/genetics ; Fetal Death ; Heart Defects, Congenital/prevention & control ; Humans ; Mutation, Missense ; Neovascularization, Physiologic/drug effects ; Phenethylamines/toxicity ; Potassium Channel Blockers/toxicity ; Sulfonamides/toxicity ; Transforming Growth Factor beta/pharmacology ; Vascular Malformations/prevention & control
    Chemical Substances ERG1 Potassium Channel ; Ether-A-Go-Go Potassium Channels ; Phenethylamines ; Potassium Channel Blockers ; Sulfonamides ; Transforming Growth Factor beta ; dofetilide (R4Z9X1N2ND)
    Language English
    Publishing date 2015-04
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2426129-4
    ISSN 1941-3084 ; 1941-3149
    ISSN (online) 1941-3084
    ISSN 1941-3149
    DOI 10.1161/CIRCEP.115.002834
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Conference proceedings: The 16th Asian Pacific Congress of Cardiology (APCC).

    Jay, Patrick Y

    IDrugs : the investigational drugs journal

    2008  Volume 11, Issue 3, Page(s) 181–183

    MeSH term(s) Animals ; Cardiology/methods ; Cardiology/trends ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Humans ; Myocardial Infarction/physiopathology ; Myocardial Infarction/therapy ; Pharmacogenetics/methods ; Pharmacogenetics/trends ; Regeneration ; Stem Cell Transplantation/methods ; Stem Cell Transplantation/trends
    Language English
    Publishing date 2008-03
    Publishing country England
    Document type Congresses
    ZDB-ID 2086568-5
    ISSN 2040-3410 ; 1369-7056
    ISSN (online) 2040-3410
    ISSN 1369-7056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Tiered Sympathetic Control of Cardiac Function Revealed by Viral Tracing and Single Cell Transcriptome Profiling.

    Sharma, Sachin / Littman, Russell / Tompkins, John / Arneson, Douglas / Contreras, Jaime / Dajani, Al-Hassan / Ang, Kaitlyn / Tsanhani, Amit / Sun, Xin / Jay, Patrick Y / Herzog, Herbert / Yang, Xia / Ajijola, Olujimi A

    bioRxiv : the preprint server for biology

    2023  

    Abstract: The cell bodies of postganglionic sympathetic neurons innervating the heart primarily reside in the stellate ganglion (SG), alongside neurons innervating other organs and tissues. Whether cardiac-innervating stellate ganglionic neurons (SGNs) exhibit ... ...

    Abstract The cell bodies of postganglionic sympathetic neurons innervating the heart primarily reside in the stellate ganglion (SG), alongside neurons innervating other organs and tissues. Whether cardiac-innervating stellate ganglionic neurons (SGNs) exhibit diversity and distinction from those innervating other tissues is not known. To identify and resolve the transcriptomic profiles of SGNs innervating the heart we leveraged retrograde tracing techniques using adeno-associated virus (AAV) expressing fluorescent proteins (GFP or Td-tomato) with single cell RNA sequencing. We investigated electrophysiologic, morphologic, and physiologic roles for subsets of cardiac-specific neurons and found that three of five adrenergic SGN subtypes innervate the heart. These three subtypes stratify into two subpopulations; high (NA1a) and low (NA1b and NA1c) Npy-expressing cells, exhibit distinct morphological, neurochemical, and electrophysiologic characteristics. In physiologic studies in transgenic mouse models modulating NPY signaling, we identified differential control of cardiac responses by these two subpopulations to high and low stress states. These findings provide novel insights into the unique properties of neurons responsible for cardiac sympathetic regulation, with implications for novel strategies to target specific neuronal subtypes for sympathetic blockade in cardiac disease.
    Language English
    Publishing date 2023-01-19
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.01.18.524575
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Tiered sympathetic control of cardiac function revealed by viral tracing and single cell transcriptome profiling.

    Sharma, Sachin / Littman, Russell / Tompkins, John D / Arneson, Douglas / Contreras, Jaime / Dajani, Al-Hassan / Ang, Kaitlyn / Tsanhani, Amit / Sun, Xin / Jay, Patrick Y / Herzog, Herbert / Yang, Xia / Ajijola, Olujimi A

    eLife

    2023  Volume 12

    Abstract: The cell bodies of postganglionic sympathetic neurons innervating the heart primarily reside in the stellate ganglion (SG), alongside neurons innervating other organs and tissues. Whether cardiac-innervating stellate ganglionic neurons (SGNs) exhibit ... ...

    Abstract The cell bodies of postganglionic sympathetic neurons innervating the heart primarily reside in the stellate ganglion (SG), alongside neurons innervating other organs and tissues. Whether cardiac-innervating stellate ganglionic neurons (SGNs) exhibit diversity and distinction from those innervating other tissues is not known. To identify and resolve the transcriptomic profiles of SGNs innervating the heart, we leveraged retrograde tracing techniques using adeno-associated virus (AAV) expressing fluorescent proteins (GFP or Td-tomato) with single cell RNA sequencing. We investigated electrophysiologic, morphologic, and physiologic roles for subsets of cardiac-specific neurons and found that three of five adrenergic SGN subtypes innervate the heart. These three subtypes stratify into two subpopulations; high (NA1a) and low (NA1b and NA1c) neuropeptide-Y (NPY) -expressing cells, exhibit distinct morphological, neurochemical, and electrophysiologic characteristics. In physiologic studies in transgenic mouse models modulating NPY signaling, we identified differential control of cardiac responses by these two subpopulations to high and low stress states. These findings provide novel insights into the unique properties of neurons responsible for cardiac sympathetic regulation, with implications for novel strategies to target specific neuronal subtypes for sympathetic blockade in cardiac disease.
    MeSH term(s) Mice ; Animals ; Neurons/metabolism ; Stellate Ganglion/metabolism ; Heart ; Neuropeptide Y/metabolism ; Gene Expression Profiling
    Chemical Substances Neuropeptide Y
    Language English
    Publishing date 2023-05-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Intramural
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.86295
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A single misstep in cardiac development explains the co-occurrence of tetralogy of fallot and complete atrioventricular septal defect in Down syndrome.

    Nguyen, Hoang H / Jay, Patrick Y

    The Journal of pediatrics

    2014  Volume 165, Issue 1, Page(s) 194–196

    Abstract: Tetralogy of Fallot and a complete atrioventricular septal defect are thought to arise by distinct mechanisms, yet their co-occurrence is a recognized association. Analysis of the prevalence of co-occurrence in Down syndrome suggests a common ... ...

    Abstract Tetralogy of Fallot and a complete atrioventricular septal defect are thought to arise by distinct mechanisms, yet their co-occurrence is a recognized association. Analysis of the prevalence of co-occurrence in Down syndrome suggests a common developmental basis. Trisomy 21 may perturb cardiac progenitor cells before they enter the heart tube.
    MeSH term(s) Child, Preschool ; Down Syndrome/complications ; Down Syndrome/physiopathology ; Heart Septal Defects ; Humans ; Infant ; Mitral Valve Insufficiency/complications ; Mitral Valve Insufficiency/epidemiology ; Mitral Valve Insufficiency/physiopathology ; Tetralogy of Fallot/complications ; Tetralogy of Fallot/epidemiology ; Tetralogy of Fallot/physiopathology
    Language English
    Publishing date 2014-04-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3102-1
    ISSN 1097-6833 ; 0022-3476
    ISSN (online) 1097-6833
    ISSN 0022-3476
    DOI 10.1016/j.jpeds.2014.02.065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top